Get App Open
In App
Lending
Lending
Open App
Success
Alert
Please select a Day.
Info

Mangalam Drugs & Organics Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
xpert
Have a query? Talk to Experts LIVE

38/100
25.94
0.54 (2.13%)

As on 05 Dec, 2025 | 11:29

Open Trading A/c
Day Range
25.03
26.55
L H
52 Week Range
23.94
124.89
L H
Volume
85,177
*
i

* BSE Market Depth (05 Dec 2025)

BUY SELL
QTY PRICE PRICE QTY
674 26.31 26.49 11
50 26.30 26.50 150
387 26.23 26.57 269
5 26.14 26.58 1002
125 26.06 26.59 2000
5075 Total Total 3432
Bid / Ask
26.31 / 26.49
38/100
25.98
0.65 (2.57%)

As on 05 Dec, 2025 | 11:29

Open Trading A/c
Day Range
25.30
26.44
L H
52 Week Range
24.08
129.90
L H
Volume
11,088
*
i

* BSE Market Depth (05 Dec 2025)

BUY SELL
QTY PRICE PRICE QTY
674 26.31 26.49 11
50 26.30 26.50 150
387 26.23 26.57 269
5 26.14 26.58 1002
125 26.06 26.59 2000
5075 Total Total 3432
Bid / Ask
26.31 / 26.49
NSE
MC Essentials
47% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Low Financial Strength, Low Growth Trend Stock at Discounted Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 25.78
          Previous Close 25.40
          Volume 85,177.00
          Value (Lacs) 22.09
            VWAP 25.72
          Beta
          Mkt Cap (Rs. Cr.) 41
          High 26.55
          Low 25.03
          UC Limit 26.67
          LC Limit 24.13
          52 Week High 124.89
          52 Week Low 23.94
          Face Value 10.00
          All Time High 442.40
          All Time Low 3.50
          20D Avg Volume 338,005
          20D Avg Delivery(%) 61.22
          Book Value Per Share 93.48
          Dividend Yield 0.00
          TTM EPS See historical trend -12.51
          TTM PE See historical trend -- (Low PE)
          P/B See historical trend 0.28 (Low P/B)
          Sector PE 40.19

          Advanced Chart

          Click here to expand
          xpert

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          38/100
          Low Financial Strength, Low Growth Trend Stock at Discounted Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 79.23% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 50.30% in Sep 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          10 out of 16 years Mangalam Drugs & Organics has given negative returns in December.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          December 57.50% (2013) 22.46% -40.96% (2015) -11.95% 0.96%

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling Mangalam Drugs

          What's your call on Mangalam Drugs today?

          Read 0 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          03 Dec, 2025

          Share India Securities Limited

          Qty 203229 Price 24.05 % Traded 1.27
          03 Dec, 2025

          Gaurav Chandrakant Shah

          Qty 100000 Price 23.94 % Traded 0.62
          03 Dec, 2025

          Share India Securities Limited

          Qty 37718 Price 24.48 % Traded 0.24
          02 Dec, 2025

          Share India Securities Limited

          Qty 91065 Price 25.43 % Traded 0.58
          02 Dec, 2025

          Share India Securities Limited

          Qty 7569 Price 25.97 % Traded 0.05
          01 Dec, 2025

          Share India Securities Limited

          Qty 847027 Price 28.64 % Traded 5.78
          01 Dec, 2025

          Tata Capital Limited

          Qty 372770 Price 28.18 % Traded 2.50
          01 Dec, 2025

          Mansi Share And Stock Broking Private Limited

          Qty 369271 Price 28.36 % Traded 2.49

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Mangalam Drugs 25.27 -0.51 40.00 - 0.27 4.51 -79.25 6 318 0.54
          Sun Pharma 1,804.30 -0.77 432,912.01 41.43 5.99 15.13 -0.50 10,980 52,578 0.03
          Divis Labs 6,405.00 -0.99 170,032.63 68.42 11.36 14.63 5.07 2,191 9,360 0.00
          Torrent Pharma 3,764.60 -0.82 127,411.17 59.54 16.98 25.17 11.99 1,911 11,516 0.40
          Cipla 1,516.50 -0.30 122,498.50 22.51 3.93 16.90 1.22 5,291 27,547 0.00

          About the Company

          Mangalam Drugs and Organics Limited is an India-based company engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The Companys segments include bulk drugs, and chemicals and others.
          {"success":1,"data":{"address":{"address1":"Rupam Building, 3rd Floor,","address2":"\n239, P.D. Mello Road,,\nNear GPO,","city":"Mumbai","state":"Maharashtra","pincode":"400001","telephone1":"022-22616200","telephone2":"022-22616300","fax1":"022-62619090","fax2":"","email":"contactus@mangalamdrugs.com","web":"http:\/\/www.mangalamdrugs.com"},"management":[{"name":"Govardhan Murlidhar Dhoot","designation":"Chairman & Managing Director"},{"name":"Brijmohan Murlidhar Dhoot","designation":"Whole Time Director"},{"name":"Praveen Saxena","designation":"Independent Director"},{"name":"Rakesh Kishinchand Milwani","designation":"Non Exe.Non Ind.Director"},{"name":"Rukmesh Prabhukumar Dhandhania","designation":"Independent Director"}],"registrars":{"name":"MUFG Intime India Pvt. Ltd.","address1":"C 101, 247 Park,\nL.B.S. Marg, Vikhroli (West),","address2":"","address3":"","address4":"","telephone":"022-49186270, 49186200","fax":"022-49186060","email":"rnt.helpdesk@linkintime.co.in","internet":"http:\/\/www.linkintime.co.in","city":"Mumbai","state":"Maharashtra","pincode":"400083"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"532637","nseId":"MANGALAM","series":"EQ","isinid":"INE584F01014"}}}
          • Registered Office

          • Registrars

          • Management

            • Govardhan Murlidhar Dhoot

              Chairman & Managing Director

            • Brijmohan Murlidhar Dhoot

              Whole Time Director

            • Praveen Saxena

              Independent Director

            • Rakesh Kishinchand Milwani

              Non Exe.Non Ind.Director

            • Rukmesh Prabhukumar Dhandhania

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              532637

            • NSE:

              MANGALAM

            • Series

              EQ

            • ISIN

              INE584F01014

          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
          Close Gen AI Masterclass